Leser

Kosan Acquired by Bristol-Myers for 233% Premium

Can't this article be edited?
It's about a month since "no name" commented on the mistake of putting in BMS for BMY and people are still accessing the article and getting a bit confused by the inaccuracies of the first paragraph.
Also, the company name should have appeared with the first use of the stock symbol, not using the symbol instead of the name in the introductory sentence.